175 related articles for article (PubMed ID: 1395665)
21. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
[TBL] [Abstract][Full Text] [Related]
22. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
23. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.
Yamamoto K; Loskutoff DJ
J Clin Invest; 1996 Jun; 97(11):2440-51. PubMed ID: 8647936
[TBL] [Abstract][Full Text] [Related]
24. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma.
Montemurro P; Conese M; Altomare DF; Memeo V; Colucci M; Semeraro N
Int J Clin Lab Res; 1995; 25(4):195-200. PubMed ID: 8788547
[TBL] [Abstract][Full Text] [Related]
25. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia.
Levi M; Schultz MJ; Rijneveld AW; van der Poll T
Crit Care Med; 2003 Apr; 31(4 Suppl):S238-42. PubMed ID: 12682446
[TBL] [Abstract][Full Text] [Related]
26. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
[TBL] [Abstract][Full Text] [Related]
27. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
28. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities.
Sitrin RG; Brubaker PG; Fantone JC
Am Rev Respir Dis; 1987 Apr; 135(4):930-6. PubMed ID: 3565941
[TBL] [Abstract][Full Text] [Related]
29. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
Van Leer C; Stutz M; Haeberli A; Geiser T
Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.
Chapman HA; Allen CL; Stone OL
Am Rev Respir Dis; 1986 Mar; 133(3):437-43. PubMed ID: 3954252
[TBL] [Abstract][Full Text] [Related]
31. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
32. [Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary fibrosis].
Ikeda T; Hirose N; Koto H; Hirano H; Shigematsu N
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):448-51. PubMed ID: 2796052
[TBL] [Abstract][Full Text] [Related]
33. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.
Hasday JD; Bachwich PR; Lynch JP; Sitrin RG
Exp Lung Res; 1988; 14(2):261-78. PubMed ID: 3371278
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
35. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
36. Lack of evidence for abnormal fibrinolysis in chronic low back pain.
Zebouni LN; Helliwell PS; Davies JA; Boothby M; Wright V
Br J Rheumatol; 1993 Feb; 32(2):132-4. PubMed ID: 7679035
[TBL] [Abstract][Full Text] [Related]
37. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
[TBL] [Abstract][Full Text] [Related]
38. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome.
Keane MP; Donnelly SC; Belperio JA; Goodman RB; Dy M; Burdick MD; Fishbein MC; Strieter RM
J Immunol; 2002 Dec; 169(11):6515-21. PubMed ID: 12444162
[TBL] [Abstract][Full Text] [Related]
39. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
40. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
